215 related articles for article (PubMed ID: 36197967)
1. Metabolic modulation of synaptic failure and thalamocortical hypersynchronization with preserved consciousness in Glut1 deficiency.
Rajasekaran K; Ma Q; Good LB; Kathote G; Jakkamsetti V; Liu P; Avila A; Primeaux S; Enciso Alva J; Markussen KH; Marin-Valencia I; Sirsi D; Hacker PMS; Gentry MS; Su J; Lu H; Pascual JM
Sci Transl Med; 2022 Oct; 14(665):eabn2956. PubMed ID: 36197967
[TBL] [Abstract][Full Text] [Related]
2. Glut1 deficiency (G1D): epilepsy and metabolic dysfunction in a mouse model of the most common human phenotype.
Marin-Valencia I; Good LB; Ma Q; Duarte J; Bottiglieri T; Sinton CM; Heilig CW; Pascual JM
Neurobiol Dis; 2012 Oct; 48(1):92-101. PubMed ID: 22683290
[TBL] [Abstract][Full Text] [Related]
3. Triheptanoin for glucose transporter type I deficiency (G1D): modulation of human ictogenesis, cerebral metabolic rate, and cognitive indices by a food supplement.
Pascual JM; Liu P; Mao D; Kelly DI; Hernandez A; Sheng M; Good LB; Ma Q; Marin-Valencia I; Zhang X; Park JY; Hynan LS; Stavinoha P; Roe CR; Lu H
JAMA Neurol; 2014 Oct; 71(10):1255-65. PubMed ID: 25110966
[TBL] [Abstract][Full Text] [Related]
4. Isolation of the murine Glut1 deficient thalamocortical circuit: wavelet characterization and reverse glucose dependence of low and gamma frequency oscillations.
Solis EM; Good LB; Granja Vázquez R; Patnaik S; Hernandez-Reynoso AG; Ma Q; Angulo G; Dobariya A; Cogan SF; Pancrazio JJ; Pascual JM; Jakkamsetti V
bioRxiv; 2023 Aug; ():. PubMed ID: 37645928
[TBL] [Abstract][Full Text] [Related]
5. Isolation of the murine Glut1 deficient thalamocortical circuit: wavelet characterization and reverse glucose dependence of low and gamma frequency oscillations.
Solis EM; Good LB; Vázquez RG; Patnaik S; Hernandez-Reynoso AG; Ma Q; Angulo G; Dobariya A; Cogan SF; Pancrazio JJ; Pascual JM; Jakkamsetti V
Front Neurosci; 2023; 17():1191492. PubMed ID: 37829723
[TBL] [Abstract][Full Text] [Related]
6. A new mouse model of GLUT1 deficiency syndrome exhibits abnormal sleep-wake patterns and alterations of glucose kinetics in the brain.
Furuse T; Mizuma H; Hirose Y; Kushida T; Yamada I; Miura I; Masuya H; Funato H; Yanagisawa M; Onoe H; Wakana S
Dis Model Mech; 2019 Sep; 12(9):. PubMed ID: 31399478
[TBL] [Abstract][Full Text] [Related]
7. Topography of brain glucose hypometabolism and epileptic network in glucose transporter 1 deficiency.
Akman CI; Provenzano F; Wang D; Engelstad K; Hinton V; Yu J; Tikofsky R; Ichese M; De Vivo DC
Epilepsy Res; 2015 Feb; 110():206-15. PubMed ID: 25616474
[TBL] [Abstract][Full Text] [Related]
8. A concise study of acetazolamide in glucose transporter type 1 deficiency (G1D) epilepsy.
Málaga I; Avila A; Primeaux S; Park JY; Pascual JM
Epilepsia; 2023 Sep; 64(9):e184-e189. PubMed ID: 37335529
[TBL] [Abstract][Full Text] [Related]
9. Lenticular nuclei to thalamic ratio on PET is useful for diagnosis of GLUT1 deficiency syndrome.
Natsume J; Ishihara N; Azuma Y; Nakata T; Takeuchi T; Tanaka M; Sakaguchi Y; Okai Y; Ito Y; Yamamoto H; Ohno A; Kidokoro H; Hattori A; Nabatame S; Kato K
Brain Dev; 2021 Jan; 43(1):69-77. PubMed ID: 32739099
[TBL] [Abstract][Full Text] [Related]
10. Disrupted basal ganglia-thalamocortical loops in focal to bilateral tonic-clonic seizures.
He X; Chaitanya G; Asma B; Caciagli L; Bassett DS; Tracy JI; Sperling MR
Brain; 2020 Jan; 143(1):175-190. PubMed ID: 31860076
[TBL] [Abstract][Full Text] [Related]
11. Brain metabolism modulates neuronal excitability in a mouse model of pyruvate dehydrogenase deficiency.
Jakkamsetti V; Marin-Valencia I; Ma Q; Good LB; Terrill T; Rajasekaran K; Pichumani K; Khemtong C; Hooshyar MA; Sundarrajan C; Patel MS; Bachoo RM; Malloy CR; Pascual JM
Sci Transl Med; 2019 Feb; 11(480):. PubMed ID: 30787166
[TBL] [Abstract][Full Text] [Related]
12. Variety of symptoms of GLUT1 deficiency syndrome in three-generation family.
Winczewska-Wiktor A; Hoffman-Zacharska D; Starczewska M; Kaczmarek I; Badura-Stronka M; Steinborn B
Epilepsy Behav; 2020 May; 106():107036. PubMed ID: 32247176
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of epileptogenesis by 2-deoxy-d-glucose is accompanied by increased cerebral glucose supply, microglial activation and reduced astrocytosis.
Leiter I; Bascuñana P; Bengel FM; Bankstahl JP; Bankstahl M
Neurobiol Dis; 2019 Oct; 130():104510. PubMed ID: 31212069
[TBL] [Abstract][Full Text] [Related]
14. s-ketamine enhances thalamocortical and corticocortical synaptic transmission in acute murine brain slices
Bieber M; Schwerin S; Kreuzer M; Klug C; Henzler M; Schneider G; Haseneder R; Kratzer S
Front Syst Neurosci; 2022; 16():1044536. PubMed ID: 36618009
[TBL] [Abstract][Full Text] [Related]
15. Glucose transporters in brain in health and disease.
Koepsell H
Pflugers Arch; 2020 Sep; 472(9):1299-1343. PubMed ID: 32789766
[TBL] [Abstract][Full Text] [Related]
16. Isolated P/Q Calcium Channel Deletion in Layer VI Corticothalamic Neurons Generates Absence Epilepsy.
Bomben VC; Aiba I; Qian J; Mark MD; Herlitze S; Noebels JL
J Neurosci; 2016 Jan; 36(2):405-18. PubMed ID: 26758833
[TBL] [Abstract][Full Text] [Related]
17. Suppression of thalamocortical oscillations following traumatic brain injury in rats.
Kao C; Forbes JA; Jermakowicz WJ; Sun DA; Davis B; Zhu J; Lagrange AH; Konrad PE
J Neurosurg; 2012 Aug; 117(2):316-23. PubMed ID: 22631688
[TBL] [Abstract][Full Text] [Related]
18. Altered thalamic GABAA-receptor subunit expression in the stargazer mouse model of absence epilepsy.
Seo S; Leitch B
Epilepsia; 2014 Feb; 55(2):224-32. PubMed ID: 24417662
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a LC-MS/MS method for quantitation of 3-hydroxypentanoic acid and 3-oxopentanoic acid in human plasma and its application to a clinical study of glucose transporter type I deficiency (G1D) syndrome.
Kallem RR; Primeaux S; Avila A; Pascual JM; Putnam WC
J Pharm Biomed Anal; 2021 Oct; 205():114335. PubMed ID: 34482182
[TBL] [Abstract][Full Text] [Related]
20. Identification of Glucose Transport Modulators In Vitro and Method for Their Deep Learning Neural Network Behavioral Evaluation in Glucose Transporter 1-Deficient Mice.
Kathote G; Ma Q; Angulo G; Chen H; Jakkamsetti V; Dobariya A; Good LB; Posner B; Park JY; Pascual JM
J Pharmacol Exp Ther; 2023 Mar; 384(3):393-405. PubMed ID: 36635085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
